Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound, on April 1 sued the Houston-based Empower Pharmacy ... of dosing errors associated with compounded semaglutide ...

Some patients might need a dosage that isn’t commercially available ... with 13 located in Texas (second only to Florida’s 14). Empower Pharmacy, in Houston, is certified as both a 503A ...

A Houston-based compounding pharmacy ... products from Empower’s facility lack key labeling information, including how to report side effects and directions for use such as dosage and ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

[O]ral semaglutide 14 mg (or flexible dosing, in PIONEER 7) was generally more effective at improving multiple cardiometabolic risk factors — including HbA 1c, [body weight], SBP, and LDL ...

Through transparent pricing, unlimited provider communication, and a lab-driven approach to dosage personalization, Sesame is making weight loss with compounded semaglutide more achievable for ...

These pharmacies are mainly regulated by state pharmacy boards ... When the FDA declared the shortage resolved for semaglutide, the main pharmaceutical ingredient in Wegovy and Ozempic, the ...

A single dose of Wave’s INHBE siRNA led to weight loss on par with semaglutide, but with no muscle loss. When administered as an add-on to semaglutide, a single dose of Wave’s INHBE siRNA ...